Achyut Healthcare Reports Nil Deviation in Utilization of Funds
Achyut Healthcare Ltd · Others (Uncategorized) · 26 Oct 2026, 11:35 pm
Achyut Healthcare Reports Nil Deviation in Utilization of Funds Achyut Healthcare Limited submitted its statement of deviation or variation under Regulation 32 of SEBI LODR Regulations for the quarter and half-year ended 30th Sep'26, confirming nil deviation across all historical fund-raising tranches. Total funds raised via public and preferential issues comprise ₹360.00 lakhs, ₹520.80 lakhs, ₹1,572.48 lakhs, and ₹348.00 lakhs across four allotments. Proceeds were deployed fully as allocated toward machinery, ongoing project capex (including laboratory equipment, AHU, civil works, and furnishings), issue expenses, and general corporate purposes without any variations.
Original exchange filing (PDF)
More announcements from Achyut Healthcare Ltd
- Unaudited Result September, 2026 · 26 Oct 2026
- Outcome of Board Meeting · 26 Oct 2026
- Achyut Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve Intimation of Board Meeting .... · 26 Oct 2026
- Intimation pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 regarding re-appointment Mr. Rutvik S. Thakkar (DIN: 09387486) as a Independent .... · 01 Oct 2026
- Intimation pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 regarding re-appointment Mrs. Sonu Lalitkumar Jain (DIN : 09387661) as a Independent .... · 01 Oct 2026
- Intimation pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 regarding re-appointment Mr. Jigen J. Modi (DIN : 03355555) as a Managing .... · 01 Oct 2026
- Voting Result at the 31st Annual General Meeting of the Company and Scrutinizer''s Report-Regulation 44(3) of the SEBI (Listing Obligation and Disclosure Requirments) Regulation, 2015 · 01 Oct 2026
- Outcome of AGM · 29 Sept 2026
